Blood Pressure Guidelines: Is Change Coming?

Michael R. Page, PharmD, RPh
Published Online: Wednesday, December 4, 2013
Follow Pharmacy_Times:
Using a benefit-based approach instead of a treat-to-target approach in determining how to treat hypertension could help prevent more cardiovascular events with less medication.




A more individualized set of treatment guidelines for prescription of blood pressure–lowering medications could prevent more cardiovascular events while using less medication than is the case with current guidelines, according to the results of a new study.
 
According to study authors, the current approach, based on blood pressure targets, has led some patients to overuse antihypertensive medications and other patients to underuse the medications. Instead of treating to a target level, the new study advises prescribers to decide which patients are the best candidates for antihypertensive treatment by assessing each patient's cardiovascular risk. The study was published in the November 19, 2013, issue of Circulation.
 
The researchers used data from the National Health and Nutrition Examination Survey (NHANES) III to determine the effects of a 5-year course of antihypertensive medication in terms of quality-adjusted life-years. The data was representative of 176 million Americans between 30 and 85 years of age with no history of severe congestive heart failure and no history of cardiovascular events (stroke or myocardial infarction).
 
For more than half of patients (55%), an antihypertensive regimen based on the treat-to-target approach would be identical to the regimen with the benefit-based approach. However, over 5 years, the benefit-based approach reduced medication use by 6% while preventing 900,000 more cardiovascular events and saving 2.8 million more quality-adjusted life years compared with the treat-to-target approach.
 


Related Articles
Medtronic’s CoreValve System is now approved for first-of-its-kind “valve-in-valve” replacement.
A veritable alphabet soup of hypertension guidelines have been released over the past year. Here is what you need to know.
Veterans with post-traumatic stress disorder face greater odds of developing heart failure.
Patients with limited life expectancy may see improvement in their quality of life if they stop taking statins.
Latest Issues
  • photo
    Pharmacy Times
    photo
    Health-System Edition
    photo
    Directions in Pharmacy
    photo
    OTC Guide
    photo
    Generic Supplements
  • photo
    Pharmacy Careers
    photo
    Specialty Pharmacy Times
    photo
    Generic
$auto_registration$